Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Medinotec (MDNC) EBITDA Margin (2022 - 2025)

Historic EBITDA Margin for Medinotec (MDNC) over the last 4 years, with Q4 2025 value amounting to 26.13%.

  • Medinotec's EBITDA Margin rose 145800.0% to 26.13% in Q4 2025 from the same period last year, while for Nov 2025 it was 22.44%, marking a year-over-year increase of 129000.0%. This contributed to the annual value of 23.08% for FY2025, which is 308300.0% up from last year.
  • Per Medinotec's latest filing, its EBITDA Margin stood at 26.13% for Q4 2025, which was up 145800.0% from 11.11% recorded in Q3 2025.
  • Medinotec's EBITDA Margin's 5-year high stood at 40.99% during Q1 2025, with a 5-year trough of 108.23% in Q3 2022.
  • For the 4-year period, Medinotec's EBITDA Margin averaged around 4.53%, with its median value being 4.34% (2025).
  • The largest annual percentage gain for Medinotec's EBITDA Margin in the last 5 years was 923200bps (2023), contrasted with its biggest fall of -119800bps (2023).
  • Over the past 4 years, Medinotec's EBITDA Margin (Quarter) stood at 12.58% in 2022, then tumbled by -95bps to 24.56% in 2023, then soared by 147bps to 11.54% in 2024, then skyrocketed by 126bps to 26.13% in 2025.
  • Its last three reported values are 26.13% in Q4 2025, 11.11% for Q3 2025, and 4.59% during Q2 2025.